Eris
Eris, officially known as Eris Lifesciences, is a prominent player in the Indian pharmaceutical industry, headquartered in India. Founded in 2007, the company has rapidly established itself as a leader in the development and marketing of high-quality generic medications, particularly in the therapeutic areas of diabetes, cardiovascular health, and respiratory diseases. With a strong operational presence across India and expanding international markets, Eris is recognised for its commitment to innovation and quality. The company’s core offerings include a diverse range of formulations that are distinguished by their efficacy and affordability, catering to the needs of healthcare professionals and patients alike. Eris has achieved significant milestones, including a robust portfolio of over 100 products and a growing market share, positioning itself as a trusted name in the pharmaceutical sector.
DitchCarbon Score
How does Eris's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Research Services industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
Eris's score of 18 is lower than 93% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Eris's reported carbon emissions
In 2022, Eris reported total carbon emissions of approximately 11,344,910 kg CO2e, a slight increase from about 10,797,420 kg CO2e in 2021. The emissions breakdown for 2022 includes Scope 1 emissions of about 70,360 kg CO2e, Scope 2 emissions of approximately 11,268,750 kg CO2e, and Scope 3 emissions remaining constant at about 5,810 kg CO2e. Despite the increase in total emissions, Eris has not disclosed any specific reduction targets or initiatives aimed at decreasing their carbon footprint. The company has reported emissions across all three scopes, indicating a comprehensive approach to tracking their environmental impact. However, without defined climate commitments or reduction strategies, the future trajectory of their emissions remains uncertain.
Unlock detailed emissions data
Access structured emissions data, company-specific emission factors, and source documents
| 2021 | 2022 | |
|---|---|---|
| Scope 1 | 109,560 | 00,000 |
| Scope 2 | 10,682,060 | 00,000,000 |
| Scope 3 | 5,810 | 0,000 |
Industry emissions intensity
Location emissions intensity
Reduction initiatives & disclosure networks
Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.
Eris is not committed to any reduction initiatives we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.
